NUCLEA BIOTECHNOLOGIES TO ANNOUNCE PAUL DOWD CHAIR AT DANA-FARBER CANCER INSTITUTE

December 14, 2012

Nuclea Biotechnologies will officially announce the establishment of the Paul M. Dowd Chair in Molecular Oncologic Pathology in honor of the Berkshire County Jimmy Fund Council, creating Dana-Farber Cancer Institute’s first Chair of Molecular Oncologic Pathology.

What: Nuclea Biotechnologies Reception & Speaking Program

When: Sunday, December 16, 2012 2:30 pm

Where: Berkshire Museum
               39 South Street
               Pittsfield, MA 01201

Who: Patrick Muraca, President & CEO, Nuclea Biotechnologies
           Dr. Massimo Loda, Director, Dana Farber Center for Molecular Oncologic Pathology
           Pittsfield Mayor Daniel L. Bianchi
           State Senator Benjamin Downing
           Paul M. Dowd, Founder and President, Berkshire County Jimmy Fund
           Suzanne Fountain, Assistant Vice President/Director of the Jimmy Fund
           Jim Mazzer, Executive Vice President of Berkshire County Jimmy Fund

Photo and interview opportunities: After a speaking program, speakers will be available for additional comment and photos.  The site will be available for photographs as well. 

Members of the press should please RSVP to Conor Yunits at (617) 695-0369 or conor@libertysquaregroup.com. Images for publication are available upon request.

Nuclea Biotechnologies, Inc is headquartered in Pittsfield, Massachusetts. Nuclea has three lines of business, each of which is operated by a separate wholly-owned subsidiary: Nuclea Diagnostic Laboratories (“NDL”) which has developed and is commercializing unique diagnostic tests for colon, breast, leukemia, lung and prostate cancer; Nuclea Biomarkers (“NBM”) which performs research leading to novel molecular oncology therapeutics and diagnostics for the pharmaceutical and biotechnology industries and performs services by analyzing and testing the efficacy and validating other indications of existing therapeutics utilizing a highly characterized and consented patient database; and Nuclea Biotherapeutics (“NBT”) which develops novel therapeutics..

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.